Signaling pathways activated in a unique mast cell line where interleukin-3 supports survival and stem cell factor is required for a proliferative response.

Abstract:

:Stem cell factor (SCF) and interleukin-3 (IL-3) both act on several target hematopoietic populations, including mast cells. We have isolated a unique murine mast cell line, B6M, that is phenotypically similar to immature mast cells. For B6M cells, IL-3 is a survival factor and alone does not stimulate proliferation. SCF can stimulate proliferation of B6M cells, and together IL-3 and SCF synergize to stimulate optimal proliferation and long-term growth. A sustained induction of c-myc is observed only in the presence of SCF (with or without IL-3). In B6M cells, both IL-3 and SCF stimulate phosphorylation of Shc and activation of the Ras, Raf-1, MAPK pathway. Interestingly, IL-3 plus SCF synergistically activate MAPK. IL-3, but not SCF, leads to activation of Jak 2 and Stat 5 and induces pim-1 expression. From these data, we suggest that the induction of pim-1 and c-myc is independently regulated. Furthermore, IL-3-stimulated activation of the Jak 2/Stat 5 pathway, induction of pim-1, and activation of the Ras/MAPK pathway are insufficient to mediate proliferation of B6M cells. The unusual IL-3 response of B6M cells provides a useful model to dissect signals required for IL-3-stimulated survival and proliferation.

journal_name

Blood

journal_title

Blood

authors

O'Farrell AM,Ichihara M,Mui AL,Miyajima A

subject

Has Abstract

pub_date

1996-05-01 00:00:00

pages

3655-68

issue

9

eissn

0006-4971

issn

1528-0020

journal_volume

87

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.

    abstract::Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive malignancy derived from precursors of plasmacytoid dendritic cells. We analyzed 21 cases with array-based comparative genomic hybridization (aCGH). Complete or partial chromosomal losses largely outnumbered the gains, with common deleted reg...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-337501

    authors: Lucioni M,Novara F,Fiandrino G,Riboni R,Fanoni D,Arra M,Venegoni L,Nicola M,Dallera E,Arcaini L,Onida F,Vezzoli P,Travaglino E,Boveri E,Zuffardi O,Paulli M,Berti E

    更新日期:2011-10-27 00:00:00

  • Transcriptional and posttranscriptional modulation of human neutrophil elastase gene expression.

    abstract::Human neutrophil elastase (NE), a 29-Kd potent serine protease stored in azurophilic granules of mature neutrophils, is coded for by the NE gene, a single copy gene with 5 exons spanning a 6-kb segment of chromosome 11 at q14. With the knowledge that the NE gene expression is limited to early myeloid cell differentiat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yoshimura K,Crystal RG

    更新日期:1992-05-15 00:00:00

  • Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.

    abstract::Meis1 is a homeodomain transcription factor coexpressed with Hoxa9 in most human acute myeloid leukemias (AMLs). In mouse models of leukemia produced by Hoxa9, Meis1 accelerates leukemogenesis. Because Hoxa9 immortalizes myeloid progenitors in the absence of Meis1 expression, the contribution of Meis1 toward leukemia ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-12-4664

    authors: Wang GG,Pasillas MP,Kamps MP

    更新日期:2005-07-01 00:00:00

  • Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma.

    abstract::Chromosomal rearrangements affecting RUNX1 and CBFB are common in acute leukemias. These mutations result in the expression of fusion proteins that act dominant-negatively to suppress the normal function of the Runt-related transcription factor 1 (RUNX)/core binding factor beta (CBFbeta) complexes. In addition, loss-o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-04-1447

    authors: Kundu M,Compton S,Garrett-Beal L,Stacy T,Starost MF,Eckhaus M,Speck NA,Liu PP

    更新日期:2005-11-15 00:00:00

  • PIP2-dependent regulation of Munc13-4 endocytic recycling: impact on the cytolytic secretory pathway.

    abstract::Cytotoxic lymphocytes clear infected and transformed cells by releasing the content of lytic granules at cytolytic synapses, and the ability of cytolytic effectors to kill in an iterative manner has been documented previously. Although bidirectional trafficking of cytolytic machinery components along the endosomal pat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-324160

    authors: Capuano C,Paolini R,Molfetta R,Frati L,Santoni A,Galandrini R

    更新日期:2012-03-08 00:00:00

  • Synergistic inhibition of platelet activation by plasmin and prostaglandin I2.

    abstract::Endothelial cell prostacyclin (PGI2) inhibits platelet activation by raising platelet cyclic AMP. Previously, platelet activation was also shown to be blocked by plasmin formed by endothelium-derived tissue plasminogen activator (TPA). We have now studied interactions between PGI2 and plasmin in the control of platele...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schafer AI,Zavoico GB,Loscalzo J,Maas AK

    更新日期:1987-05-01 00:00:00

  • Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites.

    abstract::Congenital afibrinogenemia is a rare inherited coagulopathy, characterized by very low or unmeasurable plasma levels of immunoreactive fibrinogen. So far, 25 mutations have been identified in afibrinogenemia, 17 in the Aalpha, 6 in the gamma, and only 2 in the Bbeta fibrinogen-chain genes. Here, 2 afibrinogenemic prob...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-06-1647

    authors: Spena S,Duga S,Asselta R,Malcovati M,Peyvandi F,Tenchini ML

    更新日期:2002-12-15 00:00:00

  • Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity.

    abstract::Severe elevation of red blood cell number is often associated with hypertension and thromboembolism resulting in severe cardiovascular complications. However, some individuals such as high altitude dwellers cope well with an increased hematocrit level. We analyzed adaptive mechanisms to excessive erythrocytosis in our...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0283

    authors: Vogel J,Kiessling I,Heinicke K,Stallmach T,Ossent P,Vogel O,Aulmann M,Frietsch T,Schmid-Schönbein H,Kuschinsky W,Gassmann M

    更新日期:2003-09-15 00:00:00

  • The use of radiolabeled and fluorescein-labeled antiglobulins in assays to predict platelet transfusion outcome.

    abstract::We used both radiolabeled and fluorescein-labeled antiglobulins in assays to detect antibodies against platelets in multiply transfused patients to determine the value of these tests in predicting the outcome of platelet transfusion in such patients. In 15 allosensitized patients, we studied 68 single-donor platelet t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ware R,Reisner EG,Rosse WF

    更新日期:1984-05-01 00:00:00

  • Gadd45a regulates hematopoietic stem cell stress responses in mice.

    abstract::Gadd45a has been involved in DNA damage response and in many malignancies, including leukemia. However, the function of Gadd45a in hematopoietic stem cells (HSCs) remains unknown. Here, we reported that Gadd45a-deficient (Gadd45a(-/-)) mice showed a normal hematologic phenotype under homeostatic conditions. However, f...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-05-504084

    authors: Chen Y,Ma X,Zhang M,Wang X,Wang C,Wang H,Guo P,Yuan W,Rudolph KL,Zhan Q,Ju Z

    更新日期:2014-02-06 00:00:00

  • Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.

    abstract::Caspases play a critical role in regulation of apoptosis, cell differentiation, inflammation, and innate immunity, and several are mutated or have altered expression in non-Hodgkin lymphoma (NHL). To study the impact of genetic variation in caspases on NHL risk, we analyzed tag single nucleotide polymorphisms (SNPs) i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-01-198697

    authors: Lan Q,Morton LM,Armstrong B,Hartge P,Menashe I,Zheng T,Purdue MP,Cerhan JR,Zhang Y,Grulich A,Cozen W,Yeager M,Holford TR,Vajdic CM,Davis S,Leaderer B,Kricker A,Schenk M,Zahm SH,Chatterjee N,Chanock SJ,Rothman N

    更新日期:2009-07-09 00:00:00

  • Mapping of genes that control the antibody response to human factor IX in mice.

    abstract::We tested the hypothesis that the antibody response to human factor IX in mice is controlled by genetic factors, especially histocompatibility antigens. Seven inbred mouse strains were immunized against human factor IX by adenoviral gene transfer or serial injections of human factor IX protein. A/J mice had the highes...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-1126

    authors: Lozier JN,Tayebi N,Zhang P

    更新日期:2005-02-01 00:00:00

  • Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation")

    abstract::Recently, we described a new genetic disorder (the "hereditary hyperferritinemia-cataract syndrome") clinically characterized by the combination of elevated serum ferritin and congenital bilateral nuclear cataract, both cotransmitted as an autosomal dominant trait. In affected subjects, hyperferritinemia (ranging from...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Girelli D,Corrocher R,Bisceglia L,Olivieri O,De Franceschi L,Zelante L,Gasparini P

    更新日期:1995-12-01 00:00:00

  • Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.

    abstract::In eighty-three patients with confirmed deep vein thrombosis, the fibrinolytic system was studied before and after a 10-minute venous occlusion. Blood was collected at least 3 months after the last acute episode, and PAI-1 antigen and activity, as well as tissue-type plasminogen activator (t-PA) antigen, urokinase-typ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nguyen G,Horellou MH,Kruithof EK,Conard J,Samama MM

    更新日期:1988-08-01 00:00:00

  • L-selectin shedding affects bacterial clearance in the lung: a new regulatory pathway for integrin outside-in signaling.

    abstract::Pneumonia induced by Gram-negative bacteria is a common and serious disease associated with high morbidity and mortality. Elimination of bacterial pathogens relies on the recruitment and functions of neutrophils. The adhesion molecule L-selectin has recently been implicated in integrin activation in neutrophils (insid...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000685

    authors: Cappenberg A,Margraf A,Thomas K,Bardel B,McCreedy DA,Van Marck V,Mellmann A,Lowell CA,Zarbock A

    更新日期:2019-10-24 00:00:00

  • Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.

    abstract::Internal tandem duplication (ITD) of the fms-related tyrosine kinase-3 (FLT3) gene occurs in 30% of acute myeloid leukemias (AMLs) and confers a poor prognosis. Thirteen relapsed or chemo-refractory FLT3-ITD(+) AML patients were treated with sorafenib (200-400 mg twice daily). Twelve patients showed clearance or near ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2011-06-363960

    authors: Man CH,Fung TK,Ho C,Han HH,Chow HC,Ma AC,Choi WW,Lok S,Cheung AM,Eaves C,Kwong YL,Leung AY

    更新日期:2012-05-31 00:00:00

  • Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma.

    abstract::It has been proposed that CD4 T-cell responses to Staphylococcus aureus (SA) can inadvertently enhance neoplastic progression in models of skin cancer and cutaneous T-cell lymphoma (CTCL). In this prospective study, we explored the effect of transient antibiotic treatment on tumor cells and disease activity in 8 patie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2018888107

    authors: Lindahl LM,Willerslev-Olsen A,Gjerdrum LMR,Nielsen PR,Blümel E,Rittig AH,Celis P,Herpers B,Becker JC,Stausbøl-Grøn B,Wasik MA,Gluud M,Fredholm S,Buus TB,Johansen C,Nastasi C,Peiffer L,Kubat L,Bzorek M,Eriksen JO,K

    更新日期:2019-09-26 00:00:00

  • Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease.

    abstract::Chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplant reflects a complex immune response resulting in chronic damage to multiple tissues. Previous studies indicated that donor B cells and the antibodies they produce play an important role in the development of cGVHD. To understa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-08-801001

    authors: Wang KS,Kim HT,Nikiforow S,Heubeck AT,Ho VT,Koreth J,Alyea EP,Armand P,Blazar BR,Soiffer RJ,Antin JH,Cutler CS,Ritz J

    更新日期:2017-12-28 00:00:00

  • Expression and role of FLT3 in regulation of the earliest stage of normal granulocyte-monocyte progenitor development.

    abstract::Mice deficient in c-fms-like tyrosine kinase 3 (FLT3) signaling have reductions in early multipotent and lymphoid progenitors, whereas no evident myeloid phenotype has been reported. However, activating mutations of Flt3 are among the most common genetic events in acute myeloid leukemia and mice harboring internal tan...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-12-258756

    authors: Böiers C,Buza-Vidas N,Jensen CT,Pronk CJ,Kharazi S,Wittmann L,Sitnicka E,Hultquist A,Jacobsen SE

    更新日期:2010-06-17 00:00:00

  • Increased death receptor resistance and FLIPshort expression in polycythemia vera erythroid precursor cells.

    abstract::Polycythemia vera (PV) is a clonal myeloproliferative disorder characterized by excessive erythrocyte production. Most patients with PV harbor an activating JAK2 mutation, but the molecular links between this mutation and erythrocyte overproduction are unknown. The interaction between death receptors and their ligands...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-07-3037

    authors: Zeuner A,Pedini F,Signore M,Ruscio G,Messina C,Tafuri A,Girelli G,Peschle C,De Maria R

    更新日期:2006-05-01 00:00:00

  • Defective delivery of iron to the developing red cell of the Belgrade laboratory rat.

    abstract::Erythroid cell iron and transferrin uptake and release was studied in the anemia of the Belgrade laboratory rat (gene symbol, b), an autosomal recessive trait characterized by hypochromia and hyperferrinemia. When reticulocyte-rich red cells were incubated in vitro with doubly (59Fe, 125I) labeled transferrin, b/b cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Edwards JA,Sullivan AL,Hoke JE

    更新日期:1980-04-01 00:00:00

  • Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.

    abstract::Lymphatic endothelial cells (LECs) induce peripheral tolerance by direct presentation to CD8 T cells (T(CD8)). We demonstrate that LECs mediate deletion only via programmed cell death-1 (PD-1) ligand 1, despite expressing ligands for the CD160, B- and T-lymphocyte attenuator, and lymphocyte activation gene-3 inhibitor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-04-427013

    authors: Tewalt EF,Cohen JN,Rouhani SJ,Guidi CJ,Qiao H,Fahl SP,Conaway MR,Bender TP,Tung KS,Vella AT,Adler AJ,Chen L,Engelhard VH

    更新日期:2012-12-06 00:00:00

  • Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo.

    abstract::Toll-like receptors (TLRs) and complement are 2 components of innate immunity that are critical for first-line host defense and elicitation of adaptive immune responses. Many pathogen-associated molecular patterns activate both TLR and complement, but whether and how these 2 systems, when coactivated in vivo, interact...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-12-063636

    authors: Zhang X,Kimura Y,Fang C,Zhou L,Sfyroera G,Lambris JD,Wetsel RA,Miwa T,Song WC

    更新日期:2007-07-01 00:00:00

  • Restoration of sensitivity to STI571 in STI571-resistant chronic myeloid leukemia cells.

    abstract::STI571 induces sustained hematologic remission in patients with chronic myeloid leukemia (CML) in chronic phase. However, in advanced phases, especially blast crisis, the leukemia usually becomes resistant within months. It has been investigated whether resistance to STI571 is stable and immutable or whether it can be...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.13.3864

    authors: Tipping AJ,Mahon FX,Lagarde V,Goldman JM,Melo JV

    更新日期:2001-12-15 00:00:00

  • Angiostatic activity of the antitumor cytokine interleukin-21.

    abstract::Interleukin-21 (IL-21) is a recently described immunoregulatory cytokine. It has been identified as a very potent immunotherapeutic agent in several cancer types in animal models, and clinical studies are ongoing. IL-21 belongs to the type I cytokine family of which other members, ie, IL-2, IL-15, and IL-4, have been ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-113878

    authors: Castermans K,Tabruyn SP,Zeng R,van Beijnum JR,Eppolito C,Leonard WJ,Shrikant PA,Griffioen AW

    更新日期:2008-12-15 00:00:00

  • Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells.

    abstract::Internal tandem duplication of the Fms-like tyrosine kinase-3 receptor (FLT3) internal tandem duplication (ITD) is found in 30% of acute myeloid leukemia (AML) and is associated with a poor outcome. In addition to tyrosine kinase inhibitors, therapeutic strategies that modulate the expression of FLT3-ITD are also prom...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-05-646497

    authors: Larrue C,Saland E,Boutzen H,Vergez F,David M,Joffre C,Hospital MA,Tamburini J,Delabesse E,Manenti S,Sarry JE,Récher C

    更新日期:2016-02-18 00:00:00

  • C-sis and C-abl expression in chronic myelogenous leukemia and other hematologic malignancies.

    abstract::Cellular oncogenes have been localized at the breakpoints of characteristic chromosomal rearrangements occurring in certain hematologic malignancies. This has been reported to result in aberrant expression of the involved oncogenes. Over 90% of chronic myelogenous leukemia (CML) is characterized by a reciprocal transl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Romero P,Blick M,Talpaz M,Murphy E,Hester J,Gutterman J

    更新日期:1986-03-01 00:00:00

  • FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs.

    abstract::Mixed-lineage leukemia (MLL)-AF4 fusion arises prenatally in high-risk infant acute pro-B-lymphoblastic leukemia (pro-B-ALL). In human embryonic stem cells (hESCs), MLL-AF4 skewed hematoendothelial specification but was insufficient for transformation, suggesting that additional oncogenic insults seem required for MLL...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-11-470146

    authors: Bueno C,Ayllón V,Montes R,Navarro-Montero O,Ramos-Mejia V,Real PJ,Romero-Moya D,Araúzo-Bravo MJ,Menendez P

    更新日期:2013-05-09 00:00:00

  • Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition.

    abstract::For most children who relapse with acute lymphoblastic leukemia (ALL), the prognosis is poor, and there is a need for novel therapies to improve outcome. We screened samples from children with B-lineage ALL entered into the ALL-REZ BFM 2002 clinical trial (www.clinicaltrials.gov, #NCT00114348) for somatic mutations ac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-04-531871

    authors: Irving J,Matheson E,Minto L,Blair H,Case M,Halsey C,Swidenbank I,Ponthan F,Kirschner-Schwabe R,Groeneveld-Krentz S,Hof J,Allan J,Harrison C,Vormoor J,von Stackelberg A,Eckert C

    更新日期:2014-11-27 00:00:00

  • The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation.

    abstract::Fanconi anemia (FA) is an autosomal recessive disease marked by developmental defects, bone marrow failure, and cancer susceptibility. FA cells are hypersensitive to DNA cross-linking and alkylating agents and accumulate in the G2 phase of the cell cycle in response to these agents. FA cells also display genomic insta...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kupfer GM,D'Andrea AD

    更新日期:1996-08-01 00:00:00